Françoise Farace

Inserm — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

39h-index4.8kcitations215works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(89), Lung Cancer Treatments and Mutations(65), Cancer Cells and Metastasis(51), Angiogenesis and VEGF in Cancer(37), Cancer, Hypoxia, and Metabolism(30)

Publications216 total

EF-FACS circulating tumor cell detection complements ctDNA-based prognosis in stratification of non-small cell lung cancer patients
2025Open Access
Patritumab deruxtecan in HR+HER2− advanced breast cancer: a phase 2 trial
Nature Medicine·2025· 3 citedOpen Access
Abstract P2-10-28: COMPASS-TNBC - A phase Ib/II, open-label, modular, dose-finding and dose-expansion study to explore safety and anti-tumor activity of novel therapeutics in patients with early relapsed mTNBC. Module 1: Dato-DXd & Module 2: Dato-DXd + durvalumab
Clinical Cancer Research·2025
270 (PB258): Molecular and pharmacological profiling of a prostate cancer PDX panel and in vitro cellular counterparts to identify resistance mechanisms and new therapeutic options
European Journal of Cancer·2024
Abstract 6913: A preclinical platform of prostate cancer PDX and derived cellular models as a tool for pharmacological screening and functional studies
Cancer Research·2024
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer
British Journal of Cancer·2024· 5 citedOpen Access
Abstract 4678: Characterization of a PDX panel covering molecular diversity of non-small cell lung cancer to accelerate the development of precision therapy
Cancer Research·2023
Supplementary Video 2 from Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells
2023Open Access
Data from Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells
2023Open Access
Supplementary Video 3 from Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells
2023Open Access
Supplementary Table 1, Figures 1-8, Movie Legends 1-4 from Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells
2023Open Access
Data from Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells
2023Open Access
Supplementary Video 3 from Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells
2023Open Access
Supplementary Video 1 from Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells
2023Open Access
Supplementary Video 4 from Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells
2023Open Access
Supplementary Table 1, Figures 1-8, Movie Legends 1-4 from Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells
2023Open Access
Supplementary Video 1 from Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells
2023Open Access
Supplementary Video 2 from Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells
2023Open Access
Supplementary Video 4 from Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells
2023Open Access
Supplementary Data - text from Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in <i>ALK</i>-Rearranged Non–Small-Cell Lung Cancer
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Marianne Oulhen(15), Philippe Vielh(11), Benjamin Besse(10), Vincent Faugeroux(10), Jean‐Charles Soria(9), Emma Pailler(9), Fanny Billiot(9), David Planchard(8), Yohann Loriot(7), Mélissa Taylor(6), Maud Ngo‐Camus(6), Nathalie Auger(5), Hanne Gahéry‐Ségard(5), Thomas Tursz(5), Jordi Remón(5), Tala Tayoun(5), Agathe Aberlenc(5), Patrycja Pawlikowska(5), Colin R. Lindsay(5), Leon W.M.M. Terstappen(5)